跳至主要内容
临床试验/NL-OMON20968
NL-OMON20968招募中不适用

A randomised, placebo controlled double blind study to assess the efficacy of a probiotic dairy product containing Lactobacillus casei Shirota on symptoms, visceroperception and inflammation in Irritable Bowel Syndrome.

Yakult Honsha Co. Ltd.1-19, 1 Chome, Higashi-ShinbashiMinato-ku 105-8660Tokyo JAPANContact person: Mr OosawaContact person in Europe: Dr S Kudo or Dr J Zhao, science managerScience department of Yakult Europe B.V.Yakult Europe B.V.Schutsluisweg 11332 EN ALMEREThe Netherlands0031(0)3652113000 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients will be included when:
  • 1. Diagnosed with IBS according to the ROME II criteria.

排除标准

  • 1. Patients who have had gastrointestinal surgery resulting in gastric resection, small intestinal or colonic resection.
  • 2. Patients who are allergic to milk protein

研究者

发起方
Yakult Honsha Co. Ltd.1-19, 1 Chome, Higashi-ShinbashiMinato-ku 105-8660Tokyo JAPANContact person: Mr OosawaContact person in Europe: Dr S Kudo or Dr J Zhao, science managerScience department of Yakult Europe B.V.Yakult Europe B.V.Schutsluisweg 11332 EN ALMEREThe Netherlands0031(0)365211300

相似试验